Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.
(Q33942533)
scientific article
scientific article
Language:
Current Data About
Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.
other details